Michał Beffinger
Impact in
-
- Tryptophan and brain disorders
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Johannes vom Berg (7 shared papers)Stanislav Pantelyushin (4 shared papers)Maries van den Broek (4 shared papers)Anurag Gupta (3 shared papers)Pierre–Alain Clavien (2 shared papers)Laura Heeb (2 shared papers)Sebastian Kobold (3 shared papers)Marcel Schneider (1 shared paper)
- Journals
- Journal of Visualized Experiments (2 papers)iScience (1 paper)Biochemical Pharmacology (1 paper)Science Translational Medicine (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- SwitzerlandGermanyChina
In The Last Decade
Michał Beffinger
11 papers receiving 248 citations
Peers
Comparison fields: 5 of 53
- Biological Psychiatry 24
- Neurology 66
- Immunology 86
- Developmental Neuroscience 12
- Psychiatry and Mental health 43
Countries citing papers authored by Michał Beffinger
This map shows the geographic impact of Michał Beffinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Beffinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Beffinger more than expected).
Fields of papers citing papers by Michał Beffinger
This network shows the impact of papers produced by Michał Beffinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Beffinger. The network helps show where Michał Beffinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Michał Beffinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 104 | |
| 2 | 2020 | 73 | |
| 3 | 2018 | 37 | |
| 4 | 2017 | 10 | |
| 5 | 2015 | 10 | |
| 6 | 2012 | 6 | |
| 7 | 2023 | 5 | |
| 8 | 2019 | 4 | |
| 9 | 2015 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2019 | 1 | |
| 12 | 2025 | 0 |
About Michał Beffinger
Michał Beffinger is a scholar working on Oncology, Molecular Biology, Immunology, Genetics and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 252 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Cells and Metastasis (2 papers), Cerebrospinal fluid and hydrocephalus (2 papers), Nanoparticle-Based Drug Delivery (2 papers), HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Biological Psychiatry (24 citations), Neurology (66 citations), Immunology (86 citations), Developmental Neuroscience (12 citations) and Psychiatry and Mental health (43 citations). Michał Beffinger has collaborated with scholars based in Switzerland, Germany and China. Frequent co-authors include Johannes vom Berg, Stanislav Pantelyushin, Maries van den Broek, Anurag Gupta, Pierre–Alain Clavien, Laura Heeb, Sebastian Kobold, Marcel Schneider, Lilian Roth and Michael Linecker. Their work appears in journals such as Journal of Visualized Experiments, iScience, Biochemical Pharmacology, Science Translational Medicine and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.